RE001 T cell therapy(Henan Cancer Hospital)

N/A

Report date: 2024/09/29 20:00:07

Base Information

Drug NameRE001 T cell therapy(Henan Cancer Hospital)
Drug Alias NameRE001RE-001
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHenan Provincial Cancer Hospital
China Registration ClassN/A

Develop Information

Active CompaniesHenan Provincial Cancer Hospital
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A